𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cellular and molecular properties associated with osteosarcoma cells

✍ Scribed by D. Benayahu; I. Shur; R. Marom; I. Meller; J. Issakov


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
279 KB
Volume
84
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Osteosarcoma cells are recognized by abnormal function that causes a primary bone tumor. Osteosarcoma cells U~2~OS and SAOS‐2 were analyzed for the expression of cell surface markers. High expression was quantified for hyaloronidase receptor (CD‐44) > moderate for integrins (CD‐51 and ‐61), > and lower for selectins (CD‐62). High mitotic capacity were demonstrated by gene expression (measured by RT‐PCR) and the protein level (measured by FACS) for cFOS, cMYC, and cJUN. The basic definition of osteosarcoma is excessive production of pathological osteoid. Expression of mRNA for matrix genes osteocalcin, osteonectin, and biglycan was studied. Osteocalcin and osteonectin were detected in RNA from primary cultured marrow stromal, trabecular bone cells, and osteosarcoma cell lines (U~2~OS, SAOS‐2). mRNA for biglycan was detected only in primary cells and MG‐63 cell line and was undetectable in RNA from U~2~OS, SAOS‐2 osteosarcoma cell lines and by RNA extracted from bone biopsies of osteosarcoma patients. The absence of biglycan message observed in osteosarcoma samples provides evidence for the alterations in the extra cellular matrix which result with non‐mineralized osteoid produced by the osteosarcoma cells. J. Cell. Biochem. 84: 108–114, 2002. Β© 2001 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Targeting Radioresistant Osteosarcoma Ce
✍ Daniel Zuch; An-Hoa Giang; Yuriy Shapovalov; Edward Schwarz; Randy Rosier; Regis πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 308 KB

## Abstract Osteosarcoma is a devastating tumor of bone, primarily affecting adolescents. Osteosarcoma tumors are notoriously radioresistant. Radioresistant cancers, including osteosarcoma, typically exhibit a considerable potential for relapse and development of metastases following treatment. Rel

Phenotypic changes associated with DYNAC
✍ Kieran L. Bransfield; Jon M. Askham; Jack P. Leek; Philip A. Robinson; Alan J. M πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 208 KB

## Abstract DYNACTIN‐2 (DCTN2) localises to chromosome 12q13‐q15, a region prone to stable amplification in several cancers. Transient DCTN2 overexpression has a significant impact on cellular phenotype primarily due to disruption of the DYNEIN‐dynactin motor. Changes reported include alterations o